Zhibo Gai Selected Research

1-deoxysphingolipid

1/2021	Oxidative stress increases 1-deoxysphingolipid levels in chronic kidney disease.
1/2020	Farnesoid X receptor activation induces the degradation of hepatotoxic 1-deoxysphingolipids in non-alcoholic fatty liver disease.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Zhibo Gai Research Topics

Disease

13	Inflammation (Inflammations) 01/2022 - 04/2015
7	Neoplasms (Cancer) 01/2022 - 10/2016
7	Obesity 01/2020 - 09/2014
5	Fibrosis (Cirrhosis) 01/2017 - 12/2008
4	Chronic Renal Insufficiency 01/2021 - 03/2019
4	Acute Kidney Injury (Acute Renal Failure) 01/2020 - 01/2017
3	Hepatocellular Carcinoma (Hepatoma) 11/2020 - 12/2019
3	Non-alcoholic Fatty Liver Disease 01/2020 - 01/2018
3	Albuminuria 10/2019 - 01/2016
3	Infections 10/2019 - 12/2017
2	Cardiovascular Diseases (Cardiovascular Disease) 01/2021 - 12/2019
2	Carcinoma (Carcinomatosis) 01/2021 - 01/2018
2	Esophageal Neoplasms (Esophageal Cancer) 01/2021 - 01/2018
2	Diabetic Cardiomyopathies 08/2020 - 01/2019
2	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2019 - 01/2016
2	Hypertension (High Blood Pressure) 01/2019 - 10/2016
2	Hypoxia (Hypoxemia) 01/2017 - 04/2015
2	Chronic Kidney Failure (Chronic Renal Failure) 04/2015 - 01/2014
2	Ureteral Obstruction 09/2010 - 12/2008
1	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2021
1	Dyslipidemias (Dyslipidemia) 01/2021
1	Kidney Diseases (Kidney Disease) 01/2021
1	Acute Liver Failure (Fulminant Hepatic Failure) 11/2020
1	Chemical and Drug Induced Liver Injury 11/2020
1	Mitochondrial Diseases (Mitochondrial Disease) 08/2020
1	Virus Diseases (Viral Diseases) 05/2020
1	COVID-19 05/2020
1	Drug-Related Side Effects and Adverse Reactions 01/2020
1	Ischemia 12/2019
1	Alzheimer Disease (Alzheimer's Disease) 12/2019
1	Renal Glycosuria 10/2019
1	Glycosuria 10/2019
1	Osteosarcoma (Osteogenic Sarcoma) 10/2019
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 10/2019
1	Malnutrition (Nutritional Deficiencies) 10/2019
1	Lung Neoplasms (Lung Cancer) 10/2019
1	Hyperlipidemias (Hyperlipidemia) 03/2019
1	Gram-Negative Bacterial Infections 02/2019

Drug/Important Bio-Agent (IBA)

7	Bile Acids and Salts (Bile Acids)IBA 12/2019 - 01/2014
6	LipidsIBA 01/2021 - 01/2016
4	Proteins (Proteins, Gene)FDA Link 01/2022 - 09/2010
4	Pharmaceutical PreparationsIBA 11/2020 - 07/2019
4	obeticholic acidIBA 01/2020 - 01/2017
3	CationsIBA 01/2021 - 01/2016
3	LigandsIBA 01/2020 - 01/2018
3	Arachidonic Acid (Vitamin F)IBA 01/2020 - 01/2018
3	Anti-Bacterial Agents (Antibiotics)IBA 10/2019 - 12/2017
3	Colistin (Coly-Mycin)FDA Link 10/2019 - 12/2017
3	AcidsIBA 07/2019 - 01/2015
3	Messenger RNA (mRNA)IBA 01/2017 - 09/2010
3	salicylhydroxamic acid (SHAM)IBA 04/2015 - 09/2014
2	1-deoxysphingolipidIBA 01/2021 - 01/2020
2	Organic Cation Transporter 2IBA 01/2021 - 01/2018
2	AntioxidantsIBA 01/2021 - 01/2017
2	NF-kappa B (NF-kB)IBA 01/2021 - 01/2018
2	Transforming Growth Factor-beta Type I ReceptorIBA 11/2020 - 01/2020
2	Docosahexaenoic AcidsIBA 08/2020 - 03/2019
2	Nucleic AcidsIBA 05/2020 - 10/2019
2	CreatinineIBA 10/2019 - 01/2017
2	EnzymesIBA 07/2019 - 12/2008
2	Glucose (Dextrose)FDA LinkGeneric 01/2019 - 04/2015
1	CD36 AntigensIBA 01/2022
1	PlatinumIBA 01/2021
1	Rhodamine 123IBA 01/2021
1	Oxaliplatin (Eloxatin)FDA LinkGeneric 01/2021
1	LipopolysaccharidesIBA 01/2021
1	Carnitine (L-Carnitine)FDA LinkGeneric 01/2021
1	Antidepressive Agents (Antidepressants)IBA 11/2020
1	nefazodone (Serzone)FDA LinkGeneric 11/2020
1	Adenosine Triphosphate (ATP)IBA 11/2020
1	PalmitatesIBA 08/2020
1	SolutionsIBA 05/2020
1	SphingolipidsIBA 01/2020
1	Lipoproteins (Lipoprotein)IBA 01/2020
1	Fatty Acids (Saturated Fatty Acids)IBA 01/2020
1	Phosphates (Orthophosphate)IBA 01/2020
1	CholesterolIBA 01/2020
1	CeramidesIBA 01/2020
1	farnesiferol BIBA 12/2019
1	GTP-Binding Proteins (G-Protein)IBA 12/2019
1	Amyloid beta-PeptidesIBA 12/2019
1	MicroRNAs (MicroRNA)IBA 12/2019
1	Biomarkers (Surrogate Marker)IBA 10/2019
1	Cystatin CIBA 10/2019
1	Folic Acid (Vitamin M)FDA LinkGeneric 10/2019
1	Folic Acid AntagonistsIBA 10/2019
1	Pemetrexed (MTA)FDA Link 10/2019
1	Methotrexate (Mexate)FDA LinkGeneric 10/2019
1	Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA 03/2019
1	Eicosapentaenoic AcidIBA 03/2019
1	Reactive Oxygen Species (Oxygen Radicals)IBA 03/2019
1	Polymyxins (Polymyxin)IBA 02/2019
1	Calcitriol Receptors (Calcitriol Receptor)IBA 01/2019
1	Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA 01/2019
1	Vitamin D FDA LinkGeneric 01/2019
1	Choline (Choline Chloride)IBA 01/2018
1	Leukotriene B4IBA 01/2018

Therapy/Procedure

3	Therapeutics 01/2020 - 01/2019
2	Drug Therapy (Chemotherapy) 01/2021 - 01/2018
1	Nephrectomy 01/2021